Engineering TCR-directed T-cells for the treatment of multiple myeloma.
Saved in:
| Title: | Engineering TCR-directed T-cells for the treatment of multiple myeloma. |
|---|---|
| Authors: | Mubin N; Division of Hematology & Oncology, Case Western Reserve University, Cleveland, OH, United States., Ignatz-Hoover JJ; Division of Hematology & Oncology, Case Western Reserve University, Cleveland, OH, United States.; Adult Hematologic Malignancies & Stem Cell Transplant Section, Seidman Cancer Center, University Hospitals Cleveland Medical Center, Cleveland, OH, United States.; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH, United States., Driscoll JJ; Division of Hematology & Oncology, Case Western Reserve University, Cleveland, OH, United States.; Adult Hematologic Malignancies & Stem Cell Transplant Section, Seidman Cancer Center, University Hospitals Cleveland Medical Center, Cleveland, OH, United States.; Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH, United States. |
| Source: | Frontiers in immunology [Front Immunol] 2026 Mar 31; Vol. 17, pp. 1755096. Date of Electronic Publication: 2026 Mar 31 (Print Publication: 2026). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2026.1755096 |
